LOS ANGELES--(BUSINESS WIRE)--CompuMed, Inc. (OTCBB:CMPD) -- a medical informatics company serving the healthcare community with diagnostic software solutions -- today announced it has received approval from the State Food and Drug Administration (SFDA) of the People’s Republic of China to market the OsteoGram system for screening, diagnosing and monitoring osteoporosis.
